Your new experience awaits. Try the new design now and help us make it even better

PERSPECTIVE article

Front. Vet. Sci.

Sec. Comparative and Clinical Medicine

Proposed treatment algorithms for dogs with chronic bronchitis associated with irreversible airway changes: bronchiectasis and/or bronchomalacia

Provisionally accepted
Aurélie  LyssensAurélie Lyssens*Elodie  RoelsElodie RoelsCécile  CLERCXCécile CLERCXFrédéric  BillenFrédéric Billen
  • Universite de Liege Faculte de Medecine, Liège, Belgium

The final, formatted version of the article will be published soon.

Chronic bronchitis (CB) in dogs involves persistent inflammation of the bronchial walls and excessive mucus production within the airways, with or without bronchial infection, and may lead to degenerative airway changes such as bronchiectasis (BE) and bronchomalacia (BM). Standardized treatment protocols for CB with concurrent BE and/or BM (BEBM) are lacking. This article proposes a therapeutic approach for dogs with CB and BEBM, based on veterinary literature and relevant human medical data. Two treatment algorithms are outlined, depending on the presence or absence of cytological evidence of bacterial infection in bronchoalveolar lavage fluid (BALF) and/or bronchial brush samples. For cases with suspected infection, indicated by intracellular bacteria on cytology, first-line therapy with oral doxycycline is recommended pending BALF culture and quantitative polymerase chain reaction (qPCR) results. If warranted, antibiotic therapy should be escalated stepwise after culture/qPCR confirmation, in accordance with antimicrobial stewardship principles. In non-infectious inflammatory cases, inhaled glucocorticoids are advised as first-line therapy and may also be used in infectious cases unresponsive to antibiotics alone. Mucoactive agents and cough suppressants are not recommended in the initial protocol but may be considered as adjunctive, symptom-targeted treatments on a case-by-case basis, avoiding unnecessary or unsupported interventions. These proposed algorithms are not intended as definitive clinical guidelines, but as a starting point for discussion and future validation. They emphasize rational and prudent use of antibiotics, alone or alongside anti-inflammatory therapy, to improve patient outcomes while minimizing antimicrobial resistance risks. Further research is needed to assess the long-term efficacy of this approach.

Keywords: Bronchi, Cough, therapy, Respiratory, canine

Received: 14 Aug 2025; Accepted: 31 Oct 2025.

Copyright: © 2025 Lyssens, Roels, CLERCX and Billen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Aurélie Lyssens, aurelie.lyssens@hotmail.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.